marijuana stocks news

Medbox Now Current in All Public Filings

Medbox, Inc. (MDBX), a leading licensing, infrastructure and security specialist, patented technology provider, and partner to the cannabis industry, today announced that the company has completed filing its full restated results and is current in all public filings.

The company filed an amended and restated Form 10 containing restated financial statements for the years ended December 31, 2012 and 2013, along with amended and restated Forms 10Q for the first, second and third quarters of 2014.

MedBox said it anticipates reporting financial results for the full 2014 year later this month, as well as conducting a conference call to discuss the results and its growth strategy.

About Medbox, Inc.

Medbox is a leading dispensary and cultivation infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Medbox utilizes its expertise to work with investors and entrepreneurs who seek to enter the cannabis sector, providing them with a high quality turn-key solution, consisting of licensing, site selection, permitting, design, and full build-out. Medbox has become a leader in providing compliance, safety, security, oversight and operational expertise to the medical and recreational cannabis industry nationwide. For more information about the company, visit www.medbox.com.

Forward-Looking Statements

The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, filing financial results for the full 2014 year, are based on current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond the company’s control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, technical advances in the industry, as well as political and economic conditions present within the industry. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law.

For more information, contact:

Janet Simmons
PondelWilkinson Inc.
310-279-5980
pwinvestor@pondel.com

Contact:
PondelWilkinson Inc.
Janet Simmons, 310-279-5980
pwinvestor@pondel.com

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CMM.V Milestone study shows dramatic reduction in pharmaceutical reliance

Milestone study shows dramatic reduction in pharmaceutical reliance among Canadian medical cannabis…

$OXIS Begins Enrolling and Treating Patients in FDA Phase 1/Phase 2 Clinical Trial

Oxis Begins Enrolling and Treating Patients in FDA Phase 1/Phase 2 Clinical…

MustGrow Biologics Corp. (MGROF) Reports Growth of Global Patent Portfolio

MustGrow Reports Growth of Global Patent Portfolio MustGrow Biologics Corp. (TSXV: MGRO)…